Previous Close | 0.9600 |
Open | 0.9700 |
Bid | 0.9500 x N/A |
Ask | 0.9700 x N/A |
Day's Range | 0.9600 - 0.9700 |
52 Week Range | 0.8600 - 1.7600 |
Volume | |
Avg. Volume | 73,275 |
Market Cap | 91.24M |
Beta (5Y Monthly) | 1.30 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0420 |
Earnings Date | Aug 25, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 3.25 |
Nanalysis Scientific Corp. ("the Company", (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR machines and MRI technology for healthcare and industrial applications announces that on Thursday, August 25, 2022, the Company will put out a press release and Chief Executive Officer Sean Krakiwsky and Interim Chief Financial Officer Randall McRae will host a conference call at 5:00 P.M. Eastern Time to discuss the results for the quarter June 30, 2022.
Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) ("Nanalysis" or the "Company") announces that the current CFO, Luke Caplette, is stepping down as CFO, but will remain with the Company as a part-time consultant to assist the transition to a new CFO. The Company is pleased that its Corporate Controller, Randall McRae, has been appointed interim-CFO.
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...